ACE-031 1mg Pre-Mixed Pen

Product Overview

Direct Anti Peptide is proud to offer the ACE-031 1mg Pre-Mixed Pen — a researcher-ready, high-purity peptide delivery system engineered for convenience and reproducibility in laboratory settings. ACE-031 is a recombinant fusion protein that acts as a soluble decoy receptor for ActRIIB (activin receptor type IIB), effectively sequestering myostatin and related ligands that suppress skeletal muscle development. This pre-mixed pen format is ideal for research teams seeking a streamlined, accurate, and contamination-minimised approach to peptide administration in controlled in vitro and in vivo research environments.

The complete kit includes:

• 1 x Pre-Mixed Cartridge — peptide combined with Bacteriostatic Water, ready for immediate research use
• 1 x Peptide Cartridge Pen — precision dosing instrument for consistent delivery
• 1 x Pen Carry Case — protective storage and transport solution
• Needle Tips — included for laboratory compatibility

Peptide Structure & Amino Acid Sequence

ACE-031 is a fusion protein consisting of the extracellular domain of the human activin receptor type IIB (ActRIIB) linked to the Fc region of human immunoglobulin IgG1. This structural configuration enables ACE-031 to bind with high affinity to myostatin (GDF-8), activin A, GDF-11, and other TGF-β superfamily ligands that negatively regulate muscle mass. By acting as a ligand trap, ACE-031 prevents these inhibitory proteins from engaging endogenous ActRIIB receptors on muscle cells, thereby disinhibiting anabolic signalling pathways relevant to skeletal muscle hypertrophy research.

Chemical & Physical Characteristics

ACE-031 is characterised by the following research-grade physical and chemical attributes:

• Type: Recombinant Fusion Protein / Soluble Receptor
• Target: Activin Receptor Type IIB (ActRIIB) ligands including myostatin
• Purity: ≥98% as verified by HPLC and mass spectrometry
• Formulation: Lyophilised peptide pre-mixed with Bacteriostatic Water in cartridge format
• Appearance: Clear to slightly opalescent solution upon reconstitution
• Molecular Classification: TGF-β superfamily ligand antagonist

Purity & Analytical Verification (HPLC & MS)

Every batch of ACE-031 supplied by Direct Anti Peptide undergoes rigorous analytical testing to confirm identity, purity, and structural integrity. High-Performance Liquid Chromatography (HPLC) is employed to verify that each unit achieves a minimum purity threshold of ≥98%, while Mass Spectrometry (MS) confirms the molecular weight and sequence fidelity of the fusion protein. Researchers can rely on these quality benchmarks for consistent, reproducible experimental outcomes across all study phases.

Quality Control & Lyophilisation Integrity

Prior to pre-mixing and cartridge loading, ACE-031 is produced in lyophilised form under strict aseptic manufacturing conditions. The lyophilisation process preserves the structural conformation and biological activity of the peptide, ensuring long-term stability and protection against degradation during storage and transit. Each pre-mixed cartridge is sealed under inert conditions to maintain sterility and product integrity from our facility to your laboratory.

Safety, Handling & Laboratory Precautions

ACE-031 1mg Pre-Mixed Pen is strictly intended for use by trained research professionals in appropriately equipped laboratory environments. Standard laboratory safety protocols must be observed at all times, including the use of appropriate personal protective equipment (PPE) such as gloves, eye protection, and lab coats. Researchers should follow all applicable institutional biosafety guidelines when handling recombinant fusion proteins. This product must not be used outside of a controlled research setting.

Reconstitution, Packaging & Storage

The ACE-031 1mg Pre-Mixed Pen arrives pre-loaded with Bacteriostatic Water, eliminating the need for manual reconstitution and reducing preparation time in the laboratory. The cartridge is housed within a precision-engineered peptide pen for consistent and measurable delivery. For optimal stability, store the pre-mixed cartridge refrigerated at 2–8°C and protect from direct light. Refer to product documentation for specific handling protocols relevant to your research application. Do not freeze the pre-mixed cartridge.

Intended Research Use & Market Positioning

ACE-031 has been investigated in preclinical and early-stage research contexts for its potential relevance to conditions involving muscle wasting, including Duchenne muscular dystrophy (DMD) and other musculoskeletal disorders. Research applications include the study of myostatin inhibition, skeletal muscle hypertrophy signalling, bone density modulation, and the broader TGF-β ligand pathway. Direct Anti Peptide positions ACE-031 as a premium-grade research reagent for scientists, academic institutions, and pharmaceutical research organisations seeking reliable, high-purity peptide tools for laboratory investigation.

Ordering, Availability & Fulfillment

Direct Anti Peptide offers ACE-031 1mg Pre-Mixed Pen for sale online with fast, reliable fulfilment. Order now to take advantage of our competitive best-price guarantee and efficient dispatch process. Researchers requiring larger quantities for extended studies can purchase a pack of 3 cartridges for additional value. All orders are processed promptly and shipped with appropriate cold-chain packaging to maintain product integrity during transit. Buy online today and experience the Direct Anti Peptide standard of quality and service.

Legal & Regulatory Disclaimer

For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications. ACE-031 1mg Pre-Mixed Pen is sold exclusively as a laboratory research reagent. Direct Anti Peptide makes no claims regarding the therapeutic, prophylactic, or diagnostic utility of this product. All research conducted using this product must comply with applicable local, national, and international regulations governing the use of recombinant proteins and research peptides. It is the sole responsibility of the purchasing institution or researcher to ensure full regulatory compliance within their jurisdiction prior to ordering.